Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?

Alejandro M. Gomez, Nick Willcox, Peter C. Molenaar, Wim A. Buurman, Pilar Martinez-Martinez, Marc H. De Baets, Mario Losen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)48-59
JournalAnnals of the New York Academy of Sciences
Publication statusPublished - 2012


  • bortezomib
  • plasma cell
  • myasthenia gravis
  • proteasome inhibition
  • autoimmunity

Cite this